This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Insights & Events

Filter

Content Type

Format

Service

Industry

Date

Showing 1-12 of 403 Search Results

Life Sciences

Introduction to PDABs: How US states are addressing high-cost prescription drugs
- Infographics
- October 17, 2025
Life Sciences

Keytruda & PD-(L)1: Life after programmed death (Part 3)
- CRA Insights
- October 14, 2025
Life Sciences

Navigating competitive arenas in rare disease
- Infographics
- October 10, 2025
Advanced Analytics in Life Sciences

CRA's RADAR Insights: Impact of US pricing strategies on orphan drug pricing in Germany - Part 3
- CRA Insights
- October 1, 2025
Life Sciences

The unexploited potential of data systems tracking medicines utilization: An opportunity to improve access to oncology combination therapies
- Articles
- September 29, 2025
Life Sciences

Key Health Care Antitrust and Competition Takeaways from ASHEcon 2025
- CRA Insights
- September 26, 2025
Life Sciences

The impact of price controls on rare disease medicines access and lessons for the US
- Reports
- September 25, 2025
Life Sciences

Frances Hendry joins CRA's Life Sciences Practice
- CRA News
- September 23, 2025
Market Research in Life Sciences

Brand strategy with forecast and key performance indicators
- CRA Insights
- September 22, 2025
International Arbitration

Dr. Gregory Bell named Exceptional Expert in Power Players report on International Arbitration
- Awards & Recognition
- September 15, 2025
Life Sciences Policy

Patient burden associated with acute & chronic resistant infections
- Infographics
- September 15, 2025
Life Sciences

Keytruda and PD(L)1: Life after programmed death (Part 2)
- CRA Insights
- September 10, 2025